Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P10828: Variant p.Ala317Thr

Thyroid hormone receptor beta
Gene: THRB
Feedback?
Variant information Variant position: help 317 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Alanine (A) to Threonine (T) at position 317 (A317T, p.Ala317Thr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from small size and hydrophobic (A) to medium size and polar (T) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In GRTHD; impairs hormone binding. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 317 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 461 The length of the canonical sequence.
Location on the sequence: help PCEDQIILLKGCCMEIMSLR A AVRYDPESETLTLNGEMAVT The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         PCEDQIILLKGCCMEIMSLRAAVRYDPESETLTLNGEMAVT

Mouse                         PCEDQIILLKGCCMEIMSLRAAVRYDPDSETLTLNGEMAVT

Rat                           PCEDQIILLKGCCMEIMSLRAAVRYDPDSETLTLNGEMAVT

Chicken                       PCEDQIILLKGCCMEIMSLRAAVRYDPESETLTLNGEMAVT

Zebrafish                     PCEDQIILLKGCCMEIMSLRAAVRYDPESDTLTLNGEMAVT

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 461 Thyroid hormone receptor beta
Domain 217 – 461 NR LBD
Region 244 – 461 Interaction with NR2F6
Binding site 331 – 331
Binding site 331 – 331
Mutagenesis 331 – 331 N -> S. No effect on thyroid hormone binding.
Helix 298 – 318



Literature citations
Two resistance to thyroid hormone mutants with impaired hormone binding.
Huber B.R.; Sandler B.; West B.L.; Cunha Lima S.T.; Nguyen H.T.; Apriletti J.W.; Baxter J.D.; Fletterick R.J.;
Mol. Endocrinol. 17:643-652(2003)
Cited for: X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 202-461 OF VARIANT PTHR HIS-316 AND VARIANT GRTHD THR-317; CHARACTERIZATION OF VARIANT PTHR HIS-316; CHARACTERIZATION OF VARIANT GRTHD THR-317; Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two 'hot spot' regions of the ligand binding domain.
Parrilla R.; Mixson A.J.; McPherson J.A.; McClaskey J.H.; Weintraub B.D.;
J. Clin. Invest. 88:2123-2130(1991)
Cited for: VARIANTS GRTHD THR-317; ARG-332; VAL-345; GLU-347; VAL-442 AND THR-453; Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor beta gene. Analysis of 15 families.
Weiss R.E.; Weinberg M.; Refetoff S.;
J. Clin. Invest. 91:2408-2415(1993)
Cited for: VARIANTS GRTHD THR-317; CYS-320; HIS-320; TRP-338; HIS-438 AND THR-453; Rapid molecular diagnosis of mutations associated with generalized thyroid hormone resistance by PCR-coupled automated direct sequencing of genomic DNA: detection of two novel mutations.
Seto D.; Weintraub B.D.;
Hum. Mutat. 8:247-257(1996)
Cited for: VARIANTS GRTHD THR-317; TRP-338; ILE-342 AND GLU-348;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.